As PHLPP1 facilitates chloride secretion, inhibitors of PHLPP1 may prove to be useful in the treatment of ADPKD, where activators of AMPK have already been shown to slow renal cystogenesis (Takiar et al., 2011). Here, PHLPP1 is linked to autosomal dominant polycystic kidney disease.